Transfusion associated graft-versus-host disease after cardiac surgery: response to antithymocyte-globulin and corticosteroid therapy.
A 63-year-old patient developed graft-versus-host disease (GVHD) after the transfusion of stored, random donor red cell concentrates with coronary artery surgery. The disease was characterised by skin rash, fever, diarrhoea, hepatic dysfunction, pancytopenia and the acquisition of cells bearing human leukocyte antigens of a blood donor. Clinical and histologic improvements were noted with antithymocyte-globulin and corticosteroid therapy, as seen in some patients with acute GVHD following allogeneic bone marrow transplantation, but the pancytopenia failed to resolve prior to a fatal cerebral haemorrhage. Early aggressive immunosuppressive therapy may be beneficial for transfusion-associated GVHD but strategies for its prevention by limitation of the use of homologous blood need to be addressed.
Prince
M
M
Alfred Hospital, Melbourne, Vic., Australia.
Szer
J
J
van der Weyden
M B
MB
Pedersen
J S
JS
Holdsworth
R F
RF
Whyte
G
G
D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D006086:Graft vs Host Disease / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D013601:T-Lymphocytes / Q000276:immunology*; D065227:Transfusion Reaction
D000961:Antilymphocyte Serum; D008775:Methylprednisolone